Developer docs
API playgroundTry for free, no card

Search company profiles

Victory Square

Full company profile

uuid00029kc

Namestring
Victory Square
Legal namestring
Victory Square Technologies Inc.
Company typeenum
Public
Founded yearint
2014
Descriptiontext

Victory Square Technologies Inc. is a Vancouver-based publicly traded venture builder (CSE: VST, FWB: 6F6, OTCMKTS: VSQTF) founded in 2014 that creates, funds, and operates early-stage technology companies across digital health, web3, gaming, VR/AR, and climate tech. The company maintains a portfolio of 25+ holdings, with six portfolio companies currently hitting liquidity events generating an approximately 9x return on capital committed. Management holds over 20% ownership, aligning interests with public shareholders, and the structure is positioned as an audited, transparent, and liquid vehicle for retail access to venture-stage investments.

The company's core operating asset is the VSDHOne healthcare infrastructure platform, operated through its wholly-owned subsidiary Hydreight Technologies (acquired February 2021). VSDHOne provides compliant direct-to-consumer telemedicine, at-home diagnostic tests, personalized digital health guidance, 24/7 provider access, and prescription delivery across all 50 U.S. states. The platform is underpinned by a 503B pharmacy license, U.S. e-script provider certification, and HIPAA compliance, and is distributed through 3,000+ nurses, 200+ physicians, and 400+ D2C brands, with 12,000+ licenses signed by Q1 2026. Hydreight generated $35.4M in FY2025 revenue (121% YoY growth) and $24.9M in Q1 2026, with management guiding to approximately $150M for FY2026. Additional subsidiaries include VS Digital Health, DiscreetCare (sensitive medical issue treatments), Insu Therapeutics (buccal semaglutide delivery advancing to Phase II), and Pawsible Ventures (a $10M pet health fund and incubator launched in 2025).

The business model combines venture investment returns (transaction-based monetization of portfolio liquidity events) with operating-company revenue, the latter dominated by Hydreight's subscription and transactional revenue from VSDHOne services. Go-to-market is primarily B2B2C, with VSDHOne licensees (nurses, physicians, D2C brands) delivering services to end consumers across the U.S., supplemented by direct-to-consumer genetic testing subscriptions launched in May 2025. The company is also expanding into adjacent verticals such as pet health through Pawsible Ventures, and into international markets including Brazil.

Short descriptiontext

Victory Square Technologies is a publicly traded venture builder that creates, funds, and operates 25+ early-stage technology companies, with its flagship VSDHOne healthcare platform (via Hydreight) delivering compliant telemedicine and pharmacy services across all 50 U.S. states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture building services, digital health platforms, telemedicine infrastructure, technology accelerator investments, pet health ventures
Industry1 code
PRIMARYHLALADAJ
Care Navigation, Advocacy & Benefits Guidance Platforms
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code2 codes
  • Services-Prepackaged Software7372
  • Hospital & Medical Service Plans6324
Product category
Venture Capital and Digital Health Platform
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Hydreight Healthcare Infrastructure
TypeSubscription Recurring
Description

Hydreight Technologies, the largest operating subsidiary, generates revenue through its VSDHOne platform providing telemedicine, genetic testing, pharmacy services, and healthcare provider network. Revenue grew 121% YoY to $35.4M in FY2025 with $150M guidance for FY2026.

prnewswire.com
2Venture Investment Returns
TypeTransaction Fee
Description

Victory Square generates returns through monetization of portfolio company investments. With basket of 25 portfolio companies, 6 are hitting liquidity events generating almost 9x return on capital/cash committed.

victorysquare.com
3Pawsible Ventures Pet Health
TypeLicensing Royalties
Description

Pet health venture fund with $10M Fund I targeting early-stage pet health startups. Revenue through investment returns and portfolio company success.

prnewswire.com
4Genetic Testing and Wellness Subscription
TypeSubscription Recurring
Description

Subscription-based genetic testing and personalized wellness solutions generating upfront and recurring monthly revenue through VSDHOne platform.

globenewswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1VSDHOne
Description

Direct-to-consumer healthcare infrastructure platform providing compliant offerings across all 50 U.S. states, developed in partnership with Victory Square Technologies

victorysquare.com
+3 more records
Core offering1 text field

Victory Square Technologies is a publicly traded technology accelerator and venture builder that creates, funds, and executes on ideas across digital health, web3, gaming, VR/AR, and climate tech. Through its flagship subsidiary Hydreight Technologies, the company operates the VSDHOne platform, a direct-to-consumer healthcare infrastructure providing telemedicine, genetic testing, prescription delivery, and at-home diagnostics across all 50 U.S. states. It also runs Pawsible Ventures, a $10M pet health fund and incubator, and maintains a portfolio of 25+ early-stage technology companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 121% year-over-year revenue growth (FY2025)
+4 more records
Product overview1 text field

Victory Square Technologies is a venture builder providing VC-level investment access to early-stage technology companies through an audited, transparent, and liquid investment vehicle. The company operates a portfolio of 25+ portfolio companies with key holdings in digital health infrastructure (VSDHOne and Hydreight), pet health ventures (Pawsible Ventures), and peptide delivery technology (Insu Therapeutics). VSDHOne serves as the core healthcare infrastructure platform powering Hydreight's telemedicine and pharmacy services across all 50 U.S. states, while DiscreetCare provides a consumer-facing mobile app for sensitive medical issues. The portfolio also includes companies in VR/AR, blockchain, gaming, and climate tech sectors.

Product and service6 records
1VSDHOne Platform
CategoryDigital Health Platform
Description

Healthcare infrastructure platform covering compliant offerings across all 50 U.S. states, enabling direct-to-consumer healthcare services including telemedicine, genetic testing, and prescription delivery through a network of licensed medical providers.

2Hydreight
CategoryDigital Health Platform
Description

Digital health platform providing on-demand and on-site mobile health, pharmaceutical, and wellness services. Offers IV therapy, telemedicine, and medispa treatments with a 503B pharmacy license enabling services in all 50 U.S. states.

3DiscreetCare
CategoryDigital Health Mobile App
Description

Mobile application providing treatment for sensitive medical issues, offering access to testing, treatment, and prescriptive medicinal remedies from the convenience and privacy of a mobile device.

4Pawsible Ventures
CategoryVenture Capital / Pet Health
Description

Pet health-focused venture fund and incubator platform supporting early-stage companies in the animal health ecosystem across veterinary care, diagnostics, and wellness.

5VSDHOne Genetic Testing and Wellness Solution
CategoryConsumer Genomics / Wellness
Description

Personalized genetic testing and wellness solution offering at-home DNA testing kits with personalized health plans including nutrition, fitness, supplementation, and medication compatibility insights via subscription.

6Insu Therapeutics (Buccal Semaglutide Delivery)
CategoryPharmaceutical Delivery Technology
Description

Peptide delivery platform company developing a buccal semaglutide delivery system using Novo Nordisk-manufactured Semaglutide, targeting alternative delivery for peptide therapeutics.

Scale indicator20 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeOthers
Description

Vancouver-based startup accelerator with 80+ global accelerator partners providing deal flow, startup access, and co-investment opportunities for Victory Square's venture building operations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Insu Therapeutics, a Victory Square portfolio company, uses Semaglutide manufactured by Novo Nordisk for its buccal peptide delivery program, completing milestone pre-clinical evaluation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Insu Therapeutics received approval from UBC's Research Ethics Board for Phase I animal studies to support future human studies of its buccal Semaglutide delivery program.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Portfolio company FansUnite Entertainment entered global blockchain integration partnership with World Poker Tour for gaming and wagering technology.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Portfolio company Immersive Tech appointed HTC China President Alvin Wang Graylin to its Board of Directors, bringing XR/VR expertise.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Portfolio company entered sales and distribution agreement for Safetest 15 Minute Covid-19 Rapid Test for North America.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public D2C telehealth company offering virtual care, prescription products and at-home diagnostics. Comparable to VSDHOne's combination of telemedicine, prescription delivery and direct-to-consumer subscription revenue.

TypeDirect peer
Description

Public D2C platform for prescription pricing, telehealth and pharmacy benefits. Comparable to VSDHOne's pharmacy-licensed, nationwide consumer health infrastructure and subscription-based monetization.

TypeBroad incumbent
Description

Large public telehealth platform serving enterprise, payer and consumer markets. Overlaps with VSDHOne's virtual care capability but at enterprise/B2B scale rather than D2C; useful benchmark for 50-state telehealth infrastructure maturity.

TypeBroad incumbent
Description

Public pet health and wellness products company with manufacturing, distribution and veterinary services. Useful broader-market comparable for Pawsible Ventures' portfolio companies targeting pet health infrastructure, diagnostics and wellness.

5Ro
TypeDirect peer
Description

Private D2C telehealth and online pharmacy operating across all 50 U.S. states. Closest product/market analogue to Hydreight's VSDHOne in telemedicine + pharmacy + at-home diagnostics, though at substantially larger scale.

TypeDirect peer
Description

Publicly listed IP commercialization and venture-building group. Comparable business model to Victory Square: publicly traded vehicle providing retail investors access to a portfolio of early-stage technology companies.

TypeDirect peer
Description

Publicly traded venture builder that incubates and spins out technology companies. Directly comparable to Victory Square's role as a listed holding company over a portfolio of 25+ early-stage tech bets across multiple verticals.

TypeDirect peer
Description

Public pet medical insurance provider serving North American pet owners and veterinarians. Comparable to Victory Square's Pawsible Ventures thesis targeting the $300B global pet health market with insurance, diagnostics and wellness offerings.

TypeRegional player
Description

Canadian-listed alternative investment and venture firm. Regionally comparable as a publicly traded Canadian vehicle providing access to a portfolio of early-stage and growth assets, with overlap in capital-markets audience and investor profile.

TypeDirect peer
Description

Public D2C telehealth and pharmacy platform selling prescription and OTC products directly to consumers. Most directly comparable to Hydreight's VSDHOne business in model, customer (US consumers) and reliance on a national e-script/pharmacy infrastructure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries11 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment12 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Victory Square

Venture Capital and Digital Health Platformvictorysquare.com

Victory Square Technologies is a publicly traded venture builder that creates, funds, and operates 25+ early-stage technology companies, with its flagship VSDHOne healthcare platform (via Hydreight) delivering compliant telemedicine and pharmacy services across all 50 U.S. states.

What Victory Square does

Victory Square Technologies Inc. is a Vancouver-based publicly traded venture builder (CSE: VST, FWB: 6F6, OTCMKTS: VSQTF) founded in 2014 that creates, funds, and operates early-stage technology companies across digital health, web3, gaming, VR/AR, and climate tech. The company maintains a portfolio of 25+ holdings, with six portfolio companies currently hitting liquidity events generating an approximately 9x return on capital committed. Management holds over 20% ownership, aligning interests with public shareholders, and the structure is positioned as an audited, transparent, and liquid vehicle for retail access to venture-stage investments.

The company's core operating asset is the VSDHOne healthcare infrastructure platform, operated through its wholly-owned subsidiary Hydreight Technologies (acquired February 2021). VSDHOne provides compliant direct-to-consumer telemedicine, at-home diagnostic tests, personalized digital health guidance, 24/7 provider access, and prescription delivery across all 50 U.S. states. The platform is underpinned by a 503B pharmacy license, U.S. e-script provider certification, and HIPAA compliance, and is distributed through 3,000+ nurses, 200+ physicians, and 400+ D2C brands, with 12,000+ licenses signed by Q1 2026. Hydreight generated $35.4M in FY2025 revenue (121% YoY growth) and $24.9M in Q1 2026, with management guiding to approximately $150M for FY2026. Additional subsidiaries include VS Digital Health, DiscreetCare (sensitive medical issue treatments), Insu Therapeutics (buccal semaglutide delivery advancing to Phase II), and Pawsible Ventures (a $10M pet health fund and incubator launched in 2025).

The business model combines venture investment returns (transaction-based monetization of portfolio liquidity events) with operating-company revenue, the latter dominated by Hydreight's subscription and transactional revenue from VSDHOne services. Go-to-market is primarily B2B2C, with VSDHOne licensees (nurses, physicians, D2C brands) delivering services to end consumers across the U.S., supplemented by direct-to-consumer genetic testing subscriptions launched in May 2025. The company is also expanding into adjacent verticals such as pet health through Pawsible Ventures, and into international markets including Brazil.

Victory Square firmographics

Firmographics
Name
Victory Square
Legal name
Victory Square Technologies Inc.
Website
https://victorysquare.com
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Victory Square Technologies is a publicly traded venture builder that creates, funds, and operates 25+ early-stage technology companies, with its flagship VSDHOne healthcare platform (via Hydreight) delivering compliant telemedicine and pharmacy services across all 50 U.S. states.
Ownership category
akta.pro rank

Victory Square industry classification

Industry
Product category
Venture Capital and Digital Health Platform
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Services-Prepackaged Software (7372), Hospital & Medical Service Plans (6324)
akta.pro industry
PRIMARYHLALADAJ
Care Navigation, Advocacy & Benefits Guidance Platforms
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms

Keywords

  • Venture building services
  • Digital health platforms
  • Telemedicine infrastructure
  • Technology accelerator investments
  • Pet health ventures

Where Victory Square is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Victory Square business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Hydreight Healthcare Infrastructure: Hydreight Technologies, the largest operating subsidiary, generates revenue through its VSDHOne platform providing telemedicine, genetic testing, pharmacy services, and healthcare provider network. Revenue grew 121% YoY to $35.4M in FY2025 with $150M guidance for FY2026.
  2. Venture Investment Returns: Victory Square generates returns through monetization of portfolio company investments. With basket of 25 portfolio companies, 6 are hitting liquidity events generating almost 9x return on capital/cash committed.
  3. Pawsible Ventures Pet Health: Pet health venture fund with $10M Fund I targeting early-stage pet health startups. Revenue through investment returns and portfolio company success.
  4. Genetic Testing and Wellness Subscription: Subscription-based genetic testing and personalized wellness solutions generating upfront and recurring monthly revenue through VSDHOne platform.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Victory Square product offering

Product offering

Core offering

Victory Square Technologies is a publicly traded technology accelerator and venture builder that creates, funds, and executes on ideas across digital health, web3, gaming, VR/AR, and climate tech. Through its flagship subsidiary Hydreight Technologies, the company operates the VSDHOne platform, a direct-to-consumer healthcare infrastructure providing telemedicine, genetic testing, prescription delivery, and at-home diagnostics across all 50 U.S. states. It also runs Pawsible Ventures, a $10M pet health fund and incubator, and maintains a portfolio of 25+ early-stage technology companies.

Product overview

Victory Square Technologies is a venture builder providing VC-level investment access to early-stage technology companies through an audited, transparent, and liquid investment vehicle. The company operates a portfolio of 25+ portfolio companies with key holdings in digital health infrastructure (VSDHOne and Hydreight), pet health ventures (Pawsible Ventures), and peptide delivery technology (Insu Therapeutics). VSDHOne serves as the core healthcare infrastructure platform powering Hydreight's telemedicine and pharmacy services across all 50 U.S. states, while DiscreetCare provides a consumer-facing mobile app for sensitive medical issues. The portfolio also includes companies in VR/AR, blockchain, gaming, and climate tech sectors.

Differentiator

Problem solved

Functional benefit

Brands

  • VSDHOne: Direct-to-consumer healthcare infrastructure platform providing compliant offerings across all 50 U.S. states, developed in partnership with Victory Square Technologies
  • IV Hydreight
  • DiscreetCare
  • VSDHOne Genetic Testing

Products and services

  • VSDHOne Platform Healthcare infrastructure platform covering compliant offerings across all 50 U.S. states, enabling direct-to-consumer healthcare services including telemedicine, genetic testing, and prescription delivery through a network of licensed medical providers.
  • Hydreight Digital health platform providing on-demand and on-site mobile health, pharmaceutical, and wellness services. Offers IV therapy, telemedicine, and medispa treatments with a 503B pharmacy license enabling services in all 50 U.S. states.
  • DiscreetCare Mobile application providing treatment for sensitive medical issues, offering access to testing, treatment, and prescriptive medicinal remedies from the convenience and privacy of a mobile device.
  • Pawsible Ventures Pet health-focused venture fund and incubator platform supporting early-stage companies in the animal health ecosystem across veterinary care, diagnostics, and wellness.
  • VSDHOne Genetic Testing and Wellness Solution Personalized genetic testing and wellness solution offering at-home DNA testing kits with personalized health plans including nutrition, fitness, supplementation, and medication compatibility insights via subscription.
  • Insu Therapeutics (Buccal Semaglutide Delivery) Peptide delivery platform company developing a buccal semaglutide delivery system using Novo Nordisk-manufactured Semaglutide, targeting alternative delivery for peptide therapeutics.

Quantifiable outcome

  • 121% year-over-year revenue growth (FY2025)
  • +4 more outcomes

Companies that use Victory Square

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Victory Square technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Victory Square partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Launch AcademycoreOthersVancouver-based startup accelerator with 80+ global accelerator partners providing deal flow, startup access, and co-investment opportunities for Victory Square's venture building operations.
  • Novo NordiskcoreStrategic or Co-development PartnerInsu Therapeutics, a Victory Square portfolio company, uses Semaglutide manufactured by Novo Nordisk for its buccal peptide delivery program, completing milestone pre-clinical evaluation.
  • UBC (University of British Columbia)minorStrategic or Co-development PartnerInsu Therapeutics received approval from UBC's Research Ethics Board for Phase I animal studies to support future human studies of its buccal Semaglutide delivery program.
  • World Poker TourminorGTM or Marketing PartnerPortfolio company FansUnite Entertainment entered global blockchain integration partnership with World Poker Tour for gaming and wagering technology.
  • HTC ChinaminorStrategic or Co-development PartnerPortfolio company Immersive Tech appointed HTC China President Alvin Wang Graylin to its Board of Directors, bringing XR/VR expertise.
  • ProNorth Medical CorpminorChannel Partner/ Reseller/ DistributorPortfolio company entered sales and distribution agreement for Safetest 15 Minute Covid-19 Rapid Test for North America.

Scale indicators20 records

Recent moves6 records

Expansion highlights6 records

Victory Square competitors and assessment

Company assessment

Direct peers

  • LifeMD: Public D2C telehealth company offering virtual care, prescription products and at-home diagnostics. Comparable to VSDHOne's combination of telemedicine, prescription delivery and direct-to-consumer subscription revenue.
  • GoodRx: Public D2C platform for prescription pricing, telehealth and pharmacy benefits. Comparable to VSDHOne's pharmacy-licensed, nationwide consumer health infrastructure and subscription-based monetization.
  • Ro: Private D2C telehealth and online pharmacy operating across all 50 U.S. states. Closest product/market analogue to Hydreight's VSDHOne in telemedicine + pharmacy + at-home diagnostics, though at substantially larger scale.
  • IP Group plc: Publicly listed IP commercialization and venture-building group. Comparable business model to Victory Square: publicly traded vehicle providing retail investors access to a portfolio of early-stage technology companies.
  • Allied Minds: Publicly traded venture builder that incubates and spins out technology companies. Directly comparable to Victory Square's role as a listed holding company over a portfolio of 25+ early-stage tech bets across multiple verticals.
  • Trupanion: Public pet medical insurance provider serving North American pet owners and veterinarians. Comparable to Victory Square's Pawsible Ventures thesis targeting the $300B global pet health market with insurance, diagnostics and wellness offerings.
  • Hims & Hers Health: Public D2C telehealth and pharmacy platform selling prescription and OTC products directly to consumers. Most directly comparable to Hydreight's VSDHOne business in model, customer (US consumers) and reliance on a national e-script/pharmacy infrastructure.

Broad incumbents

  • Teladoc Health: Large public telehealth platform serving enterprise, payer and consumer markets. Overlaps with VSDHOne's virtual care capability but at enterprise/B2B scale rather than D2C; useful benchmark for 50-state telehealth infrastructure maturity.
  • PetIQ: Public pet health and wellness products company with manufacturing, distribution and veterinary services. Useful broader-market comparable for Pawsible Ventures' portfolio companies targeting pet health infrastructure, diagnostics and wellness.

Regional players

  • Accelerate Financial Technologies: Canadian-listed alternative investment and venture firm. Regionally comparable as a publicly traded Canadian vehicle providing access to a portfolio of early-stage and growth assets, with overlap in capital-markets audience and investor profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Victory Square social profiles

Digital presence

Victory Square compliance and trust

Trust signal

Compliance2 records

Victory Square financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Victory Square leadership team

Management profile

Number of profiles

Profiles8 records

Victory Square subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

Victory Square funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Victory Square M&A and investment

M&A and investment

M&A7 records

Investments12 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Victory Square

What does Victory Square do?

Victory Square Technologies is a publicly traded technology accelerator and venture builder that creates, funds, and executes on ideas across digital health, web3, gaming, VR/AR, and climate tech. Through its flagship subsidiary Hydreight Technologies, the company operates the VSDHOne platform, a direct-to-consumer healthcare infrastructure providing telemedicine, genetic testing, prescription delivery, and at-home diagnostics across all 50 U.S. states. It also runs Pawsible Ventures, a $10M pet health fund and incubator, and maintains a portfolio of 25+ early-stage technology companies.

Is Victory Square a public or private company?

Victory Square is a public company. It is classified as public and is currently operating.

When was Victory Square founded?

Victory Square was founded in 2014. It employs 11 to 50 people.

Where is Victory Square based?

Victory Square is headquartered in Vancouver, Canada, in the North America region.

How does Victory Square make money?

Four revenue lines are on record. Hydreight Healthcare Infrastructure is the primary driver. The others are venture Investment Returns, pawsible Ventures Pet Health and genetic Testing and Wellness Subscription.

Who are Victory Square's main competitors?

Direct peers on record are LifeMD, GoodRx, Ro, IP Group plc, Allied Minds, Trupanion and Hims & Hers Health. Broad incumbents are Teladoc Health and PetIQ. Accelerate Financial Technologies is listed as a regional player.

Does Victory Square have an API?

No public API is recorded for Victory Square.

What industry is Victory Square in?

Victory Square's product category is Venture Capital and Digital Health Platform. Its primary akta.pro industry code is HLALADAJ, Care Navigation, Advocacy & Benefits Guidance Platforms. Its NAICS code is 524292 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanVictory Square ranks No. 2 among public firmsVictory Square Technologies ranked No. 58 overall and second among public firms on The Globe and Mail's 2026 Canada's Top Growing Companies list, with 497% revenue growth from 2022 to 2025. First-half 2026 revenue rose 434% to $53.0 million, driven by Hydreight Technologies.PR NewswireVictory Square Technologies Ranks No. 2 Among Publicly Traded Companies on The Globe and Mail's 2026 Canada's Top Growing Companies ListVictory Square Technologies ranked No. 58 on The Globe and Mail's 2026 Canada's Top Growing Companies list, with 497% revenue growth from 2022 to 2025. It holds the second-highest position among publicly traded companies, and its first-half 2026 revenue rose 434% to $53 million.YahooVictory Square Technologies Reports First-Half 2026 Revenue of $53.0 Million and Net Income of $6.5 MillionVictory Square Technologies reported Q2 2026 revenue of $28.0 million, up 421% year-over-year, and net income of $2.5 million. For the first half, revenue reached $53.0 million, up 434%, with net income of $6.5 million. Cash stood at $20.2 million and working capital at $34.5 million.Stock TitanVictory Square H1 Earnings: $53M Revenue, $6.5M Net IncomeVictory Square Technologies reported Q2 2026 revenue of $28.0 million, up 421% year-over-year, and H1 revenue of $53.0 million, up 434%. Net income was $6.5 million for H1, and cash reached $20.2 million. The company plans to support Hydreight's growth and advance Insu's peptide-delivery research in the second half of 2026.PR NewswireVictory Square Technologies Reports First-Half 2026 Revenue of $53.0 Million and Net Income of $6.5 MillionVictory Square Technologies reported Q2 2026 revenue of $28.0 million, up 421% year-over-year, and H1 revenue of $53.0 million, up 434%. Net income was $2.5 million for Q2 and $6.5 million for H1, with cash at $20.2 million and working capital at $34.5 million.Markets DailyContrasting Nebius Group (NASDAQ:NBIS) & Victory Square Technologies (OTCMKTS:VSQTF)MarketBeat published a comparative analysis of financial metrics, analyst recommendations, and risk profiles for technology companies Victory Square Technologies and Nebius Group. The report indicates that while Victory Square Technologies trades at a more affordable valuation with higher profitability ratios, Nebius Group is favored by analysts due to its stronger consensus rating and larger revenue base.PR NewswireVictory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug SubstancesVictory Square Technologies Inc. is providing shareholders with an update on Hydreight Technologies, its largest healthcare investment, following an FDA Pharmacy Compounding Advisory Committee recommendation during its July 23–24, 2026 meeting to include six peptide-related bulk drug substances — BPC-157, KPV, TB-500, MOTS-c, Semax and Epitalon — on the Section 503A Bulks List, while declining to recommend Emideltide (DSIP). Victory Square holds approximately 44.5% of Hydreight's issued common shares and notes the recommendations are non-binding, with the FDA to determine next steps through its regulatory rulemaking process; Hydreight currently offers peptide-based therapies including GLP-1 therapies, Sermorelin and Ipamorelin through its platform of 12,000+ VSDHOne licenses, 300+ physicians and operations across all 50 U.S. states. Victory Square also holds investments in Insu Therapeutics, a development-stage biotech developing a buccal drug delivery platform for peptide and biologic molecules, and Pawsible, a companion animal health initiative.Stock TitanVictory Square FDA Panel Recommends 6 Peptide SubstancesVictory Square Technologies Inc. announced on July 29, 2026 that the FDA Pharmacy Compounding Advisory Committee recommended six peptide-related bulk drug substances—BPC-157, KPV, TB-500, MOTS-c, Semax and Epitalon—for inclusion on the Section 503A Bulks List, while declining to recommend Emideltide (DSIP). Victory Square is Hydreight Technologies' largest shareholder, holding approximately 44.5% of its shares, and this regulatory development relates directly to Hydreight's digital healthcare platform which offers peptide-based therapies across all 50 U.S. states. The advisory committee's recommendations are non-binding and will be subject to FDA regulatory rulemaking before any final inclusion on the Bulks List.PR NewswireVictory Square Reports Q1 2026 Financial Results and Provides Portfolio UpdateVictory Square Technologies Inc. reported Q1 2026 financial results with revenue increasing to $24.9 million compared to $4.5 million in Q1 2025, and net income totaling approximately $3.9 million, while cash and marketable securities strengthened to approximately $31 million. The company's performance was driven primarily by Hydreight Technologies, its largest operating subsidiary, which operates a healthcare platform across all 50 U.S. states and completed a $15 million financing during the quarter. Notable portfolio developments included Insu Therapeutics completing Phase I preclinical studies for its buccal semaglutide delivery program and receiving approval to initiate Phase II studies, while Pawsible Ventures launched its inaugural pet-health venture platform with a $10 million investment fund.Stock TitanVictory Square Q1 revenue hits $24.9M, net $3.9MVictory Square Technologies Inc. announced its Q1 2026 financial results, reporting revenue of $24.9 million and net income of $3.9 million, driven primarily by its healthcare infrastructure subsidiary Hydreight Technologies. The company also provided updates on development programs at Insu Therapeutics and pet health initiatives at Pawsible Ventures, highlighting progress and strategic expansion.